This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”
MIT Technology Review Narrated
00:00
Safety claims and Russian approval history
Morganov cites Russian approval for VEGF; the episode questions the robustness of those trials.
Play episode from 06:02
Transcript
